Northern Oak Wealth Management Inc. cut its position in shares of Stryker Corporation (NYSE:SYK) by 27.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 3,100 shares of the medical technology company’s stock after selling 1,180 shares during the quarter. Northern Oak Wealth Management Inc.’s holdings in Stryker were worth $440,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Marco Investment Management LLC grew its holdings in shares of Stryker by 10.4% in the 3rd quarter. Marco Investment Management LLC now owns 70,875 shares of the medical technology company’s stock worth $10,066,000 after acquiring an additional 6,685 shares during the last quarter. Baker Chad R grew its holdings in shares of Stryker by 3.9% in the 3rd quarter. Baker Chad R now owns 18,070 shares of the medical technology company’s stock worth $2,567,000 after acquiring an additional 670 shares during the last quarter. Guardian Capital LP grew its holdings in shares of Stryker by 4.1% in the 3rd quarter. Guardian Capital LP now owns 124,492 shares of the medical technology company’s stock worth $17,680,000 after acquiring an additional 4,849 shares during the last quarter. Piedmont Investment Advisors LLC grew its holdings in shares of Stryker by 0.9% in the 3rd quarter. Piedmont Investment Advisors LLC now owns 77,882 shares of the medical technology company’s stock worth $11,061,000 after acquiring an additional 707 shares during the last quarter. Finally, California Public Employees Retirement System grew its holdings in shares of Stryker by 5.5% in the 3rd quarter. California Public Employees Retirement System now owns 762,555 shares of the medical technology company’s stock worth $108,298,000 after acquiring an additional 40,029 shares during the last quarter. Institutional investors own 74.97% of the company’s stock.

A number of equities analysts recently issued reports on the company. SunTrust Banks restated a “buy” rating and issued a $161.00 target price on shares of Stryker in a report on Monday, October 2nd. Oppenheimer set a $156.00 target price on Stryker and gave the stock a “hold” rating in a report on Monday, October 30th. Canaccord Genuity lifted their target price on Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a report on Friday, October 27th. Zacks Investment Research cut Stryker from a “hold” rating to a “sell” rating in a report on Monday, October 16th. Finally, Cowen set a $160.00 target price on Stryker and gave the stock a “buy” rating in a report on Friday, October 6th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Stryker has a consensus rating of “Hold” and an average target price of $153.19.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 7.40% of the company’s stock.

Shares of Stryker Corporation (NYSE:SYK) traded up $0.78 during trading on Tuesday, hitting $152.71. The stock had a trading volume of 826,100 shares, compared to its average volume of 1,177,418. The firm has a market capitalization of $56,857.92, a PE ratio of 24.08, a PEG ratio of 2.39 and a beta of 0.78. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a 1-year low of $116.27 and a 1-year high of $160.62.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, October 26th. The medical technology company reported $1.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.50 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker had a return on equity of 24.11% and a net margin of 14.67%. Stryker’s revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.39 earnings per share. research analysts anticipate that Stryker Corporation will post 6.47 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be given a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend is Thursday, December 28th. This is a boost from Stryker’s previous quarterly dividend of $0.43. Stryker’s dividend payout ratio (DPR) is 36.32%.

ILLEGAL ACTIVITY NOTICE: “Stryker Corporation (SYK) Shares Sold by Northern Oak Wealth Management Inc.” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of international copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/stryker-corporation-syk-shares-sold-by-northern-oak-wealth-management-inc/1759629.html.

Stryker Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.